Anti-Obesity Medications (AOMs) or GLP-1 drugs, such as Ozempic and Wegovy, are gaining popularity as diabetes and weight loss drugs in America
Although the FDA has not approved it specifically for weight loss, research indicates that it may support weight reduction
It is designed to simultaneously activate GLP-1, GIP, and glucagon receptors, offering a comprehensive approach to studying weight regulation, metabolic efficiency, and energy balance
These cells respond to several things in food: Certain amino acids can stimulate L-cells to release GLP-1, and protein-rich foods like meat, fish, eggs, dairy, and legumes are some of the strongest triggerseven without fermentation
Weekly subcutaneous injection